Fierce Pharma

SEPTEMBER 19, 2024

A study from The BMJ indicates that the newest class of migraine drugs—which includes Pfizer’s Nurtec, AbbVie’s Ubrelvy and Eli Lilly’s Reyvow—is less effective in the acute treatment of migra | A study from The BMJ indicates that the newest class of migraine drugs—which includes Pfizer’s Nurtec, AbbVie’s Ubrelvy and Eli Lilly’s Reyvow—is less effective in the acute treatment of migraines than a previous class of medicines.

Medicine 323

Medicine 323

MedCity News

SEPTEMBER 19, 2024

During a panel discussion at MedCity News’ INVEST Digital Health conference, three healthcare leaders shared their expert insight on what needs to change in order to improve the industry’s cybersecurity strategy. The post What Will It Take to Improve Healthcare Cybersecurity? appeared first on MedCity News.

Healthcare 131

Healthcare Healthcare 131

Fierce Pharma

SEPTEMBER 19, 2024

From truckloads of torn documents to avian incursions in the production plant, Granules India’s recent manufacturing reprimand from the FDA is alarming no matter which way you look at it. | Earlier this month, Granules was slapped with a Form 483 following an inspection of its Telangana facility in India that ran from Aug. 26 to Sept. 6. The FDA’s report cites six observations around poor quality control procedures, subpar cleaning, cross-contamination risks and more.

Manufacturing 320

Manufacturing FDA 320

MedCity News

SEPTEMBER 19, 2024

Months after 23andMe CEO Anne Wojcicki publicly stated she wants to take the company she co-founded private, all of the company’s independent board directors have resigned. The board letter to Wojcicki stated that its members preferred resigning over continuing to have a difference of view over the direction of the company. The post Mass Board Exodus at 23andMe Leaves Company With Tough Decisions Ahead appeared first on MedCity News.

Government 128

Government Biopharma 128

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

SEPTEMBER 19, 2024

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the 50-50 cell-therapy-focused joint venture with Fosun Pharma. | Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the cell therapy-focused joint venture with Fosun Pharma.

Pharma 264

Pharma 264

MedCity News

SEPTEMBER 19, 2024

Doctor’s offices are the front door of the American healthcare system. We owe it to them to support H.R. 2474 and put an end to annual Congressional stop-gap spending bills. The post Medicare Reimbursement for Doctors is in Critical Condition appeared first on MedCity News.

Doctors 126

Doctors Healthcare Healthcare Physicians 126

MedCity News

SEPTEMBER 19, 2024

Real change will come from disrupting the status quo. Advances in AI and a focus on prevention offer a way forward, promising not just financial rewards, but a healthier population, less strain on healthcare, and a future where “healthcare” truly means care. The post Disrupting the U.S. “Sickcare” System appeared first on MedCity News.

Healthcare 116

Healthcare Healthcare 116

Fierce Pharma

SEPTEMBER 19, 2024

Diagnosing multiple sclerosis (MS) can be an incredibly complex process for both patients and doctors. | In this episode, sponsored by Sanofi, we’re joined by Dr. Jiwon Oh to discuss the need to better understand SPMS.

Doctors 130

Doctors Patients 130

MedCity News

SEPTEMBER 19, 2024

During a panel discussion at the MedCity News INVEST Digital Health Conference, executives shared the top challenges they’re facing in the consumer diagnostic testing space. These challenges include funding and encouraging behavior change. The post What Are the Challenges in Building a Consumer-Focused Diagnostic Testing Startup? appeared first on MedCity News.

115

115

Fierce Pharma

SEPTEMBER 19, 2024

In this week's episode of "The Top Line," we’re recapping and discussing the major trends from Digitial Pharma East, w | In this week's episode of "The Top Line," we’re recapping and discussing the major trends from Digitial Pharma East.

Pharma 130

Pharma 130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

SEPTEMBER 19, 2024

Neuralink gets FDA breakthrough status for an implantable chip called Blindsight that promises to restore eyesight to the blind

FDA 111

FDA 111

Pharmaceutical Technology

SEPTEMBER 19, 2024

An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual differences in genes, environments, and lifestyles to drive better outcomes through medicine.

Medicine 105

Medicine Healthcare Healthcare Medical 105

pharmaphorum

SEPTEMBER 19, 2024

FDA turns down Vanda Pharma's tradipitant for gastroparesis, prompting a furious response from the company

FDA 111

FDA Pharma 111

PharmaTimes

SEPTEMBER 19, 2024

There is currently no national screening programme for the disease in the UK

81

81

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

SEPTEMBER 19, 2024

ICER will preempt the next Medicare drug pricing round with a 'special report' on two COPD drugs from GSK

Specialization 111

Specialization 111

PharmaVoice

SEPTEMBER 19, 2024

The disparate teams of research and commercial at J&J work closely together from the get-go.

74

74

pharmaphorum

SEPTEMBER 19, 2024

Upstream Bio has become the latest biotech to chance its arm with a public listing in the US, seeking funds for its rival to respiratory drug Tezspire.

105

105

Pharmacy Times

SEPTEMBER 19, 2024

These pharmacies address cost, understanding, and safety concerns through high-touch support and coordination.

Safety 54

Safety Patients 54

Advertisement

pharmaphorum

SEPTEMBER 19, 2024

Daiichi Sankyo's FLT3 inhibitor Vanflyta has been recommended for NHS use as a treatment for a specific form of acute myeloid leukaemia (AML) in England and Wales, the first countries in Europe to authorise use of the drug after a health technology assessment (HTA) review.

83

83

Pharmacy Times

SEPTEMBER 19, 2024

Results displayed a non-inferior immune response of the co-administered vaccines, compared to administration in individual visits.

52

52

PharmExec

SEPTEMBER 19, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Commerce

SEPTEMBER 19, 2024

The collaboration is centered around meeting track-and-trace requirements.

52

52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

LEVO Health

SEPTEMBER 19, 2024

Patient engagement is no longer just a buzzword in healthcare — it’s a critical component of delivering effective care and improving outcomes. As healthcare providers and medtech companies aim to provide more personalized and timely care, interactive health technologies are emerging as powerful tools to bridge the gap between patients and their providers.

Patients 52

Patients Healthcare Provider Healthcare Healthcare 52

Pharmaceutical Commerce

SEPTEMBER 19, 2024

Results of the Phase III CENTERSTONE study demonstrated that when Xofluza is taken by an individual with influenza, it lowers the risk of others in the household contracting it.

52

52

PharmExec

SEPTEMBER 19, 2024

Results of the Phase III HERTHENA-Lung02 trial demonstrated the superiority of patritumab deruxtecan over platinum plus pemetrexed induction chemotherapy in patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer.

Patients 52

Patients 52

Copyright Clearance Center

SEPTEMBER 19, 2024

CCC introduced RightFind Curriculum, which is the only all-in-one combined content and licensing solution that enables K–12 educators, EdTech companies, curriculum developers, and custom publishing companies to easily search for, discover, and incorporate high-quality, copyrighted content into curriculum and instructional materials, EdTech applications, and online platforms.

Education 52

Education 52

Advertisement

Distribution

Pharmaceutical Technology

SEPTEMBER 19, 2024

Before the FDA approved AstraZeneca’s Fasenra, Nucala was the only therapy for treating eosinophilic granulomatosis with polyangiitis.

FDA 52

FDA 52

Clarivate

SEPTEMBER 19, 2024

Encountering objections and questions from payers and health technology assessment (HTA) decision-makers is an unavoidable part of bringing a new pharmaceutical or medical technology to market. Payer conversations provide an opportunity to acknowledge potential issues or evidence gaps and alleviate concerns. Yet without careful planning and the development of effective objection handling resources, these concerns can cause delays and disappointment on the road to reimbursement or formulary listi

Marketing 52

Marketing Pharmaceutical Medical Insurance 52

Pharmaceutical Technology

SEPTEMBER 19, 2024

NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product sales.

Sales 52

Sales 52

PharmaTech

SEPTEMBER 19, 2024

Lilly has added a $1 billion investment to increase biologics manufacturing at its Limerick, Ireland, site while unveiling its new $800 million facility in Kinsale.

Manufacturing 52

Manufacturing 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales